Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Using credit card points can significantly enhance your vacation planning. Learn how to maximize your rewards for the best travel experiences.
20,817 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
XRP slipped about 10% over the past week, pushing the token toward the $1 floor as sellers dominate the chart. Analys...
Memory-chip stocks tumbled after a Korean market crash rippled into U.S. markets, led by SanDisk and Micron as risk-o...
Nvidia announces a breakthrough that isn’t a chip, signaling a new era for AI infrastructure. Investors react as data...
A broad pullback in the Magnificent Seven pushed the tech rally into a correction. Yet analysts say this may reflect ...
As markets shift, the question isn’t just 'do I buy index funds?'—it’s 'could picking individual stocks better positi...
A CNBC analyst contends the FedEx selloff reflects misinterpretation of the income statement, not a collapse in deman...
A bold revenue target from Micron points to a surprisingly durable AI demand wave. This piece breaks down what the gu...
SpaceX remains privately held, but chatter about a public listing fuels the myth that a superstar IPO will power the ...
Meta Platforms looks cheaper than it has in years, with growth signals that could power a turnaround by 2027. This gu...
Investors weigh AI infrastructure costs against Azure growth as Microsoft and tech peers face margin pressure. Here’s...
Strategy’s market value has slipped below the value of its own Bitcoin holdings, reversing years of a premium for BTC...